Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-05381941

Copy Product Info
😃Good
Catalog No. T36017Cas No. 1474022-02-0
Alias PF05381941

PF-05381941 is a selective and potent dual inhibitor of TAK1 and p38α with IC 50 =156 nM/186nM that inhibits the kinase activity of TAK1 by binding to its active site.

PF-05381941

PF-05381941

Copy Product Info
😃Good
Purity: 98.04%
Catalog No. T36017Alias PF05381941Cas No. 1474022-02-0
PF-05381941 is a selective and potent dual inhibitor of TAK1 and p38α with IC 50 =156 nM/186nM that inhibits the kinase activity of TAK1 by binding to its active site.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$90-In Stock
5 mg$222-In Stock
10 mg$355-In Stock
25 mg$712-In Stock
1 mL x 10 mM (in DMSO)$245-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.04%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
PF-05381941 is a selective and potent dual inhibitor of TAK1 and p38α with IC 50 =156 nM/186nM that inhibits the kinase activity of TAK1 by binding to its active site.
Targets&IC50
p38α:186 nM, TAK1:156 nM
In vitro
PF-05381941 inhibits TNF-α release from LPS-stimulated human peripheral mononuclear (PMN) cells with an IC50 value of 8 nM. [1]
SynonymsPF05381941
Chemical Properties
Molecular Weight466.53
FormulaC27H26N6O2
Cas No.1474022-02-0
SmilesN#CC1=CC=CC(=C1)N2N=C(C=C2NC(=O)NC3=CC=C(OC=4C=CN=CC4)C(=C3)C)C(C)(C)C
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (171.48 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.07 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1435 mL10.7174 mL21.4348 mL107.1742 mL
5 mM0.4287 mL2.1435 mL4.2870 mL21.4348 mL
10 mM0.2143 mL1.0717 mL2.1435 mL10.7174 mL
20 mM0.1072 mL0.5359 mL1.0717 mL5.3587 mL
50 mM0.0429 mL0.2143 mL0.4287 mL2.1435 mL
100 mM0.0214 mL0.1072 mL0.2143 mL1.0717 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-05381941 | purchase PF-05381941 | PF-05381941 cost | order PF-05381941 | PF-05381941 chemical structure | PF-05381941 in vitro | PF-05381941 formula | PF-05381941 molecular weight